DePuy ASR recall takes $271M from J&J’s Q1 bottom line

April 18, 2012 By MassDevice staff Leave a Comment

Shares of Johnson & Johnson (NYSE:JNJ) closed up a hair yesterday after the company said it added 12.5% to its bottom line, ending the day at $64.22 per share after the J&J raised its earnings guidance for the year by a pair of pennies.

The New Brunswick, N.J.-based health care conglomerate said costs associated with the recall of its DePuy ASR metal-on-metal hip implant and with litigating the 100s of personal injury lawsuits filed over the device slashed $271 million from its quarterly profits.

J&J posted profits of $3.91 billion, or $1.41 per share, on sales of $16.14 billion for the quarter, for essentially flat sales compared with profits of $3.48 billion, or $1.25 EPS, on sales of $16.17 billion during Q1 2011.

Excluding 1-time items such as the DePuy recall expenses, adjusted EPS were $1.37, 2¢ above analysts’ consensus of $1.35.

"We continue to bring meaningful innovations to our patients and customers through the strong performance of our recently launched products," said outgoing chairman & CEO William Weldon, who’s slated to cede the corner office to Alex Gorsky next week, in prepared remarks. "The dedication of the people of Johnson & Johnson gives me great confidence in the prospects of our business to deliver sustainable growth, well into the future."

Johnson & Johnson raised its top-line adjusted EPS guidance for 2012 from $5.05-$5.15 to $5.07-$5.17. Analysts on The Street are predicting adjusted EPS of $5.10 for the year.

Sales for J&J’s medical device & diagnostics segment were flat at $6.41 billion, down 0.3% compared with $6.43 billion during the same period last year. That’s largely due to a 24.1% slide for its cardiovascular unit, driven in turn by its move to exit the coronary stent business last year.

Orthopedic product sales were off by 0.7% for the quarter, at $1.49 billion. General surgery product sales rose a tick to $1.63 billion, while specialty surgery sales jumped 8.8% to $628 million.

JNJ shares opened today at $63.90, down about 0.01%.

Medtech manufacturers continue to step up during pandemic
As the coronavirus pandemic spreads across the world, contract manufacturers and OEMs continue pivoting to meet the needs of front-line healthcare providers. Here are some of the latest examples: Stryker Stryker (NYSE:SYK) recently announced that it has developed a low-cost, limited-release emergency response bed for use in hospital emergency departments, triage and pop-up areas of… […]
DeviceTalks Weekly: Ep.4 — What does Medtronic’s Puritan reveal mean for medtech?
What does Medtronic’s Puritan reveal mean for medtech? Medtronic earned plaudits and praise for sharing the design specifications for its Puritan Bennett 560 (PB560) ventilators. But will the gesture actually lead to more ventilators being manufactured? In this episode of DeviceTalks Weekly, we’ll talk with experts who will tell us what the plans do and… […]
Newest shortage: Respiratory ventilator repair manuals?
The U.S. Public Interest Research Group says that many manufacturers or respiratory ventilators do not provide access to repair documentation, limiting who can repair the equipment. The advocacy group claims this practice discourages third-party medical repair companies or in-house medical engineers from trying to fix things. So USPIRG, which also sponsors a Right to Repair Campaign, says… […]
Webinar: The digital production floor transformation: Extending your digital edge beyond core systems
Tuesday, May 5, 2020 11:30 am Eastern time / 8:30 am Pacific time Digital transformation efforts are accelerating in a variety of manufacturing areas, yet many producers stop short of digitizing their device history records (DHRs) and other shop floor data collection efforts. Despite the investments manufacturers have made in tried-and-true digitization and… […]
Hospital survey reveals front-line needs, desperate measures
Hospitals across the U.S. have begun resorting to unorthodox means of replacing or sanitizing personal protective equipment (PPE) and atypical sourcing of PPE and other supplies needed to fight the coronavirus pandemic, according to a government survey. The Department of Human Services’ Office of the Inspector General (OIG) conducted the random survey of 323 hospitals… […]
CDRH gives medtech manufacturers employee coronavirus safety tips
As certain medtech companies continue ramping up production of devices and components to fight the coronavirus, the FDA’s Center for Devices and Radiological Health (CDRH) on Sunday announced several tips to help protect medtech manufacturing employees from contracting COVID-19. In addition to frequent and thorough hand-washing, maintaining social distancing and avoiding face-touching, the agency urged… […]
Lin Engineering hastens manufacture of DC motors for fight against COVID-19
Lin Engineering — a designer and manufacturer of precision electric motors and motion systems — is prioritizing the production and supply of motors to support companies making medical devices critical in the treatment of COVID-19 patients. Morgan Hill, Calif.-based Lin Engineering said last week its highest priority is supplying motors to the makers of medical… […]
Nortech, Minnetronix may start building ventilators
Two Minnesota medtech contract manufacturers are taking a hard look at producing ventilators, including one from the plans that Medtronic made public last week to address the coronavirus outbreak. Maple Grove-based Nortech Systems (NSDQ:NSYS) told Medical Design & Outsourcing it is seriously considering starting to produce the machines based on the design specifications of Medtronic’s… […]
Materialise touts 3D-printed oxygen mask that could free up ventilators
Materialise announced today that it developed a 3D-printed device to convert standard hospital equipment into a mask to help patients breathe by creating positive pressure in the lungs. The Leuven, Belgium-based company’s Materialise NIP Connector is designed to give clinicians the ability to reduce the time that patients need access to ventilators and relieve the… […]
Plastikos implements bio-contamination testing and compliance under ISO 14698
Plastikos (Erie, Pa.) recently announced that it has implemented a formal bio-contamination testing and compliance system that’s in full compliance with ISO 14698-1 and ISO 14698-2 — a move the company described as paramount amid the COVID-19 pandemic. Plastikos and Plastikos Medical presently mold medical devices and parts within multiple ISO-7 certified cleanrooms. The new… […]
How 3D printing is enabling ventilator splitting
Amid the shortage of ventilators due to the COVID-19 pandemic, researchers are finding success using 3D printing to enable “ventilator splitting.” The search continues to go on for more machines, but there have already been government actions taken to increase amounts, while researchers have taken it into their own hands to create homemade-style ventilators. However,… […]